Can I Take Magnesium With Mounjaro (Tirzepatide)?

Print or save as PDFOpens the printable supplement log and your print dialog. No sign-up.

What the Mounjaro label says about interactions

Mounjaro is tirzepatide, a once-weekly subcutaneous injection approved as an adjunct to diet and exercise for type 2 diabetes in adults and in children 10 years and older, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes at high risk for them. It is not labeled for weight loss [1].

Its drug interactions section covers two things. First, insulin and insulin secretagogues such as sulfonylureas, because the combination raises hypoglycemia risk [1]. Second, oral medicines in general: tirzepatide delays gastric emptying and may affect how a swallowed drug is absorbed, so the label advises caution and monitoring for drugs that depend on threshold concentrations or have a narrow therapeutic index, such as warfarin [1]. For oral hormonal contraceptives, the label advises switching to a non-oral method or adding a barrier method for 4 weeks after starting and for 4 weeks after each dose escalation [1].

The overlap that matters: diarrhea and fluid loss

Diarrhea is a common adverse reaction to tirzepatide. In the pooled placebo-controlled trials in adults with type 2 diabetes, diarrhea occurred in 12% to 17% of Mounjaro-treated patients versus 9% on placebo, nausea in 12% to 18% versus 4%, vomiting in 5% to 9% versus 2%, and constipation in 6% to 7% versus 1% [1]. Any gastrointestinal adverse reaction occurred in 37.1% to 43.6% of treated patients versus 20.4% on placebo, and most reports of nausea, vomiting and diarrhea came during dose escalation and decreased over time [1].

The label also warns about acute kidney injury from volume depletion, noting that most reported events occurred in patients who had gastrointestinal reactions such as nausea, vomiting or diarrhea leading to dehydration, and that renal function should be monitored in patients reporting reactions that could lead to volume depletion, especially during initiation and dose escalation [1].

Magnesium sits on the same axis. The US Institute of Medicine set a tolerable upper intake level of 350 mg per day for magnesium from supplements and pharmacological sources, with diarrhea as the limiting effect; the limit does not apply to magnesium in food [2][5]. OTC magnesium laxative labels say to stop use and ask a doctor for rectal bleeding or no bowel movement after use, or if a laxative is needed for more than 1 week [3].

A 2023 perspective in Advances in Nutrition argued that the 350 mg limit should be re-evaluated, reporting that 7 of 10 intervention studies at 128 to 1,200 mg per day found no significant difference in diarrhea versus control. The authors are affiliated with the Center for Magnesium Education and Research, which funded the work, and 350 mg per day remains the US upper limit [2][5].

Kidney disease and high magnesium

Both OTC magnesium laxative labels say to ask a doctor before use if you have kidney disease or a magnesium-restricted diet; the magnesium citrate label also names a sodium-restricted diet [3][4]. MedlinePlus notes that side effects from high magnesium intake are uncommon except in people with significantly reduced kidney function, and that excess most often comes from supplements or magnesium-containing laxatives [6].

In a retrospective cohort of 320 hospitalized patients prescribed magnesium oxide in Japan, 75 (23%) reached a serum magnesium of 2.5 mg/dL or higher and 13 (4%) reached grade 3. Independent risk factors were eGFR 55.4 mL/min or less (OR 3.1), BUN 22.4 or more (OR 3.5), a magnesium oxide dose of 1,650 mg per day or more (OR 1.9) and 36 days or more of use (OR 2.2) [7]. Severe cases can also occur with normal kidney function: a case report described a 53-year-old woman who used magnesium laxatives regularly for chronic constipation and reached a peak serum magnesium of 10.8 mg/dL, and the authors state such cases are rare [8].

Dose and form

The recommended dietary allowance for magnesium is 400 mg per day for men aged 19 to 30 and 420 mg per day from age 31, and 310 mg per day for women aged 19 to 30 and 320 mg per day from age 31; that is a total-diet figure, not a supplement target [6]. The FDA Daily Value printed on labels is 420 mg [9].

No study tested any magnesium form together with Mounjaro. In a double-blind crossover of 12 patients with ileal resection, 100 mg of labeled magnesium diglycinate and magnesium oxide were absorbed similarly across the group (23.5% versus 22.8%), but the diglycinate was absorbed better in the four patients who absorbed oxide worst (23.5% versus 11.8%) and was better tolerated by all patients. That is a small study in a surgical population, not evidence about healthy adults [10].